[go: up one dir, main page]

DK1007053T3 - Behandling af smerte - Google Patents

Behandling af smerte

Info

Publication number
DK1007053T3
DK1007053T3 DK97937721T DK97937721T DK1007053T3 DK 1007053 T3 DK1007053 T3 DK 1007053T3 DK 97937721 T DK97937721 T DK 97937721T DK 97937721 T DK97937721 T DK 97937721T DK 1007053 T3 DK1007053 T3 DK 1007053T3
Authority
DK
Denmark
Prior art keywords
pain
treatment
dopa
antidepressant
neurotransmitters
Prior art date
Application number
DK97937721T
Other languages
Danish (da)
English (en)
Inventor
Cari Loder
Graham Cooper
David Frederick Horrobin
Original Assignee
Amarin Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Neuroscience Ltd filed Critical Amarin Neuroscience Ltd
Application granted granted Critical
Publication of DK1007053T3 publication Critical patent/DK1007053T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK97937721T 1996-08-29 1997-08-27 Behandling af smerte DK1007053T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617990.8A GB9617990D0 (en) 1996-08-29 1996-08-29 Treatment of pain

Publications (1)

Publication Number Publication Date
DK1007053T3 true DK1007053T3 (da) 2006-10-30

Family

ID=10799070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97937721T DK1007053T3 (da) 1996-08-29 1997-08-27 Behandling af smerte

Country Status (11)

Country Link
US (2) US6451788B1 (fr)
EP (1) EP1007053B1 (fr)
AT (1) ATE331521T1 (fr)
AU (1) AU733088B2 (fr)
DE (1) DE69736249T2 (fr)
DK (1) DK1007053T3 (fr)
ES (1) ES2264806T3 (fr)
GB (1) GB9617990D0 (fr)
PT (1) PT1007053E (fr)
WO (1) WO1998008520A1 (fr)
ZA (1) ZA977794B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
WO1999052539A1 (fr) * 1998-04-10 1999-10-21 Mayo Foundation For Medical Education And Research Neo-tryptophane
ES2292238T3 (es) * 1998-04-24 2008-03-01 Scarista Limited Tratamiento de la depresion y preparaciones farmaceuticas para el mismo.
GB9904252D0 (en) * 1999-02-24 1999-04-21 Worsley Andrew P Composition for the treatment of pain
US6575147B2 (en) * 1999-02-25 2003-06-10 Go-Tec Internal combustion system adapted for use of a dual fuel composition including acetylene
GB9906808D0 (en) * 1999-03-24 1999-05-19 Kilgowan Limited Formulation for treatment of pain
US6759437B2 (en) * 1999-10-04 2004-07-06 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity including cysteine
US6403657B1 (en) * 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
CA2475763A1 (fr) * 2002-02-12 2003-08-21 Cypress Bioscience, Inc. Methodes de traitement du trouble d'hyperactivite avec deficit de l'attention (thada)
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
BR0308556A (pt) * 2002-03-21 2005-05-03 Martin C Hinnz Tecnologia de otimização do segmento de sistema de serotonina e de catecolaminas
MXPA04011529A (es) * 2002-04-24 2005-08-15 Cypress Bioscience Inc Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension.
US7459464B2 (en) * 2002-05-30 2008-12-02 Neurosearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
AU2003284005B2 (en) * 2002-10-03 2009-12-17 Forest Laboratories Holdings Limited Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
CA2516653A1 (fr) * 2003-02-21 2004-09-10 Martin C. Hinz Technologie d'optimisation par segments du systeme de serotonine et de catecholamine
WO2004105690A2 (fr) * 2003-05-23 2004-12-09 Cypress Bioscience, Inc. Traitement de douleurs chroniques au moyen de chimiotherapie ou de radiotherapie
JP4638685B2 (ja) * 2003-06-10 2011-02-23 ハイデルベルガー ドルツクマシーネン アクチエンゲゼルシヤフト オフセット印刷機による印刷の際に湿し水を調量する方法
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
EP1696877A4 (fr) * 2003-11-13 2010-06-09 Gen Hospital Corp Methodes pour traiter la douleur
EP3138566B1 (fr) 2003-11-17 2022-01-26 BioMarin Pharmaceutical Inc. Traitement de la phénylcétonurie avec de la bh4
EP2436379A1 (fr) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Formule de comprimé stable
CA2588994A1 (fr) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methodes et compositions de traitement de l'hypertension pulmonaire du nouveau-ne
WO2007006003A2 (fr) 2005-07-06 2007-01-11 Sepracor Inc. Combinaisons d'eszopiclone et de trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphtalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphtalenamine, et methodes de traitement de la menopause et des troubles de l'humeur, de l'anxiete et troubles cognitifs
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
CN101273025B (zh) * 2005-09-28 2012-05-09 大赛璐化学工业株式会社 含有氰基和内酯骨架的多环酯
JP2009518415A (ja) * 2005-12-05 2009-05-07 バイオマリン ファーマシューティカル インコーポレイテッド 疾患の処置のための方法および組成物
US20090306050A1 (en) * 2006-02-03 2009-12-10 Timothy Dinan Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
WO2007100718A2 (fr) * 2006-02-24 2007-09-07 Denise Barbut Agonistes des recepteurs de la neurotensine et agonistes des recepteurs des opioides
CA2648121C (fr) 2006-03-31 2013-08-06 Sepracor Inc. Preparation d'amines et amides chiraux
JP2009538925A (ja) * 2006-05-31 2009-11-12 セプラコール， インク． ｔｒａｎｓ４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミン及びそのホルムアミドを用いる疼痛性障害の治療
WO2008089148A1 (fr) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Procédé de traitement d'un trouble métabolique ou neuropsychiatrique avec un précurseur de dérivé du bh4
US20080220104A1 (en) * 2007-03-08 2008-09-11 Cappello John V Compositions for producing satiety
RU2486899C2 (ru) 2007-04-11 2013-07-10 Байомарин Фармасьютикал Инк. Композиции тетрагидробиоптерина и способы его количественной оценки
EP2629615B1 (fr) 2010-10-22 2018-10-10 Duke University Formulations à libération prolongée de 5-hydroxytryptophane en tant que complément à des thérapies pro-sérotonergiques
JP2014503592A (ja) * 2011-01-26 2014-02-13 ニコ ワールドワイド，インコーポレイテッド 片頭痛の療法
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
ITUB20153879A1 (it) * 2015-09-24 2017-03-24 Professional Dietetics Spa Composizioni per il trattamento del dolore in pazienti sottoposti ad artroplastica elettiva

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431670A (en) * 1980-12-19 1984-02-14 Bernardo Heller D-Phenylalanine treatment
US4652559A (en) * 1982-08-16 1987-03-24 The Upjohn Company 2-(Phenylmethylene)cycloalkyl-azetidines
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
ES2184808T3 (es) 1994-10-05 2003-04-16 Cari Loder Tratamiento de la esclerosis multiple (em) y otro estados desmielinizantes empleando lofepramina en combinacion con l-fenilalanina, tirosina o triptofano y opcionalmente un compuesto de vitamina b12.
AU3451797A (en) 1996-07-05 1998-02-02 Andrew Peter Worsley Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain

Also Published As

Publication number Publication date
ZA977794B (en) 1998-04-17
WO1998008520A1 (fr) 1998-03-05
AU733088B2 (en) 2001-05-03
DE69736249T2 (de) 2007-05-24
EP1007053B1 (fr) 2006-06-28
US6989380B2 (en) 2006-01-24
GB9617990D0 (en) 1996-10-09
EP1007053A1 (fr) 2000-06-14
ATE331521T1 (de) 2006-07-15
AU4025397A (en) 1998-03-19
ES2264806T3 (es) 2007-01-16
US6451788B1 (en) 2002-09-17
US20020187958A1 (en) 2002-12-12
PT1007053E (pt) 2006-11-30
DE69736249D1 (de) 2006-08-10

Similar Documents

Publication Publication Date Title
DK1007053T3 (da) Behandling af smerte
DK0934061T3 (da) Isobutylgaba og dets derivater til behandling af smerte
DK0867178T3 (da) Non-allosteriske GABA A agonister til behandling af søvnforstyrrelser
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
SI1304327T1 (fr)
AU1718400A (en) Method for treating pain
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
BR9708109A (pt) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinametanol no tratamento de distúrbios depressivos e distúrbios bipolares
ATE256673T1 (de) Chirale phenyldihydrofuranone als pde-iv inhibitoren
DK0642791T3 (da) Anvendelse af aminosyrer med forgrenet kæde til fremstilling af et lægemiddel til behandling af tardiv dyskinesi
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
PL318292A1 (en) Application of selegyline in treating epileptic seizures
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
DE69930952D1 (de) Gesteuerte freisetzung von antidepressiva
BR0112460A (pt) Método para tratamento de sépsis
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
YU29496A (sh) So pirolidinil metil indola
TR199701613T1 (xx) Selim prostatik hiperplasyan�n tedavisi i�in melatonin agonistleri.
DK0994703T3 (da) Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS